Strides Arcolab is currently trading at Rs. 692.00, up by 69.55 points or 11.17% from its previous closing of Rs. 622.45 on the BSE.
The scrip opened at Rs. 627.00 and has touched a high and low of Rs. 705.00 and Rs. 627.00 respectively. So far 53,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1224.90 on 05-Dec-2012 and a 52 week low of Rs. 552.65 on 01-Aug-2013.
Last one week high and low of the scrip stood at Rs. 744.00 and Rs. 552.65 respectively. The current market cap of the company is Rs. 4,090 crore.
The promoters holding in the company stood at 27.39% while Institutions and Non-Institutions held 59.81% and 12.80% respectively. Strides Arcolab has received tentative approval from the US FDA for its anti aids combination drug Tenofovir Disoproxil Fumarate and Emtricitabine Tablets, 300mg and 200mg. The company is one among the 6 generics company to have received USFDA approval. This abbreviated new drug application (ANDA) has been reviewed under the expedited provisions of the President's Emergency Plan for AIDS relief (PEPFAR). The company supplies ARV products to global procurement agencies and this approval adds to the overall basket of medicines available.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
The scrip opened at Rs. 627.00 and has touched a high and low of Rs. 705.00 and Rs. 627.00 respectively. So far 53,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1224.90 on 05-Dec-2012 and a 52 week low of Rs. 552.65 on 01-Aug-2013.
Last one week high and low of the scrip stood at Rs. 744.00 and Rs. 552.65 respectively. The current market cap of the company is Rs. 4,090 crore.
The promoters holding in the company stood at 27.39% while Institutions and Non-Institutions held 59.81% and 12.80% respectively. Strides Arcolab has received tentative approval from the US FDA for its anti aids combination drug Tenofovir Disoproxil Fumarate and Emtricitabine Tablets, 300mg and 200mg. The company is one among the 6 generics company to have received USFDA approval. This abbreviated new drug application (ANDA) has been reviewed under the expedited provisions of the President's Emergency Plan for AIDS relief (PEPFAR). The company supplies ARV products to global procurement agencies and this approval adds to the overall basket of medicines available.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
No comments:
Post a Comment